ABB:NSEABB India Limited Analysis
Data as of 2026-03-15 - not real-time
₹6,392.50
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
ABB India is trading well above its intrinsic estimate, with the market price of ₹6,392.5 far exceeding the DCF‑derived fair value of roughly ₹990 and a trailing P/E of 81 versus an industry average of 29, indicating a pronounced overvaluation. Technical indicators show a bullish bias – the 20‑day SMA sits below the price, MACD is bullish, and the trend is upward – but the RSI at 68 signals near‑overbought conditions and volume is on a decreasing trend, suggesting limited upside in the near term. The company boasts strong fundamentals: revenue growth of 5.7%, gross margin near 39%, ROE of 22%, and a robust cash position of ₹58 billion against modest debt, supporting a sustainable dividend yield of 0.62% with a payout ratio around 55%. Recent material news highlights a ₹620 crore investment plan and a 4% share‑price gain in CY26, underscoring confidence in future capacity expansion and R&D initiatives. However, the high valuation multiples and overbought technical stance temper short‑term enthusiasm. Over the medium to long horizon, the combination of solid cash generation, consistent dividend policy, and strategic growth projects positions ABB India as a fundamentally sound player, albeit at a price that may require a correction before delivering attractive returns.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Market price far above DCF fair value
- RSI indicating overbought conditions
- Decreasing volume despite bullish MACD
Medium Term
1–3 yearsNeutral
Model confidence: 8/10
Key Factors
- Strong cash flow and low debt
- Sustainable dividend payout
- Ongoing 620 cr investment enhancing growth visibility
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- High ROE and solid operating margins
- Strategic expansion in electrification and automation
- Consistent dividend track record over 30 years
Key Metrics & Analysis
Financial Health
Revenue Growth5.70%
Profit Margin12.64%
P/E Ratio81.3
ROE22.39%
ROA9.11%
Debt/Equity1.08
P/B Ratio17.3
Op. Cash Flow₹12.2B
Free Cash Flow₹8.8B
Industry P/E29.1
Technical Analysis
TrendBullish
RSI68.0
Support₹5,695.00
Resistance₹6,554.00
MA 20₹6,026.63
MA 50₹5,555.44
MA 200₹5,428.40
MACDBullish
VolumeDecreasing
Fear & Greed Index72.88
Valuation
Fair Value₹990.27
Target Price₹6,022.04
Upside/Downside-5.80%
GradeOvervalued
TypeGrowth
Dividend Yield0.62%
Risk Assessment
Beta0.04
Volatility29.67%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.